Tamura Tomokazu, Fukuhara Takasuke, Uchida Takuro, Ono Chikako, Mori Hiroyuki, Sato Asuka, Fauzyah Yuzy, Okamoto Toru, Kurosu Takeshi, Setoh Yin Xiang, Imamura Michio, Tautz Norbert, Sakoda Yoshihiro, Khromykh Alexander A, Chayama Kazuaki, Matsuura Yoshiharu
Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01582-17. Print 2018 Jan 15.
The family consists of four genera, , , , and , and comprises important pathogens of human and animals. Although the construction of recombinant viruses carrying reporter genes encoding fluorescent and bioluminescent proteins has been reported, the stable insertion of foreign genes into viral genomes retaining infectivity remains difficult. Here, we applied the 11-amino-acid subunit derived from NanoLuc luciferase to the engineering of the viruses and then examined the biological characteristics of the viruses. We successfully generated recombinant viruses carrying the split-luciferase gene, including dengue virus, Japanese encephalitis virus, hepatitis C virus (HCV), and bovine viral diarrhea virus. The stability of the viruses was confirmed by five rounds of serial passages in the respective susceptible cell lines. The propagation of the recombinant luciferase viruses in each cell line was comparable to that of the parental viruses. By using a purified counterpart luciferase protein, this split-luciferase assay can be applicable in various cell lines, even when it is difficult to transduce the counterpart gene. The efficacy of antiviral reagents against the recombinant viruses could be monitored by the reduction of luciferase expression, which was correlated with that of viral RNA, and the recombinant HCV was also useful to examine viral dynamics Taken together, our findings indicate that the recombinant viruses possessing the split NanoLuc luciferase gene generated here provide powerful tools to understand viral life cycle and pathogenesis and a robust platform to develop novel antivirals against viruses. The construction of reporter viruses possessing a stable transgene capable of expressing specific signals is crucial to investigations of viral life cycle and pathogenesis and the development of antivirals. However, it is difficult to maintain the stability of a large foreign gene, such as those for fluorescence and bioluminescence, after insertion into a viral genome. Here, we successfully generated recombinant viruses carrying the 11-amino-acid subunit derived from NanoLuc luciferase and demonstrated that these viruses are applicable to and experiments, suggesting that these recombinant viruses are powerful tools for increasing our understanding of viral life cycle and pathogenesis and that these recombinant viruses will provide a robust platform to develop antivirals against viruses.
该病毒科由四个属,即 、 、 和 组成,包含人类和动物的重要病原体。尽管已有报道构建了携带编码荧光和生物发光蛋白的报告基因的重组病毒,但将外源基因稳定插入保留感染性的病毒基因组仍然困难。在此,我们将源自纳米荧光素酶的11个氨基酸亚基应用于该病毒的工程改造,然后检测了这些病毒的生物学特性。我们成功构建了携带分裂荧光素酶基因的重组病毒,包括登革病毒、日本脑炎病毒、丙型肝炎病毒(HCV)和牛病毒性腹泻病毒。通过在各自的敏感细胞系中连续传代五轮,证实了这些病毒的稳定性。重组荧光素酶病毒在每个细胞系中的增殖与亲本病毒相当。通过使用纯化的对应荧光素酶蛋白,这种分裂荧光素酶检测方法可应用于各种细胞系,即使在难以转导对应基因的情况下也是如此。抗病毒试剂对重组病毒的疗效可通过荧光素酶表达的降低来监测,这与病毒RNA的降低相关,并且重组HCV也可用于检测病毒动力学。综上所述,我们的研究结果表明,在此构建的具有分裂纳米荧光素酶基因的重组病毒为理解病毒生命周期和发病机制提供了强大工具,并为开发针对该病毒的新型抗病毒药物提供了强大平台。构建具有能够表达特定信号的稳定转基因的报告病毒对于病毒生命周期和发病机制的研究以及抗病毒药物的开发至关重要。然而,将大的外源基因,如用于荧光和生物发光的基因,插入病毒基因组后很难维持其稳定性。在此,我们成功构建了携带源自纳米荧光素酶的11个氨基酸亚基的重组病毒,并证明这些病毒适用于 和 实验,这表明这些重组病毒是增进我们对病毒生命周期和发病机制理解的强大工具,并且这些重组病毒将为开发针对该病毒的抗病毒药物提供强大平台。